IPF Summit 2022
During the IPF Summit, APIE Therapeutics will present a poster describing the novel apelin receptor agonist (APT101) and its effects in models of acute and chronic lung injury
International Workshop of Scleroderma Research
Preclinical results support the potential of APT-101 as a therapeutic for ILD, including those cases associated with SSc-ILD
APIE Therapeutics chosen as Start-Up Stadium Finalist
Start-Up Stadium was designed to provide start-up companies with the opportunity to access key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology event.
RESI JPM 2022
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors with strategic channel partners.
In 2022, RESI returns to JP Morgan in its successful virtual format, being held January 11-13, 2022. The week of JPM has been described as the World Series of early-stage life science and healthcare, bringing innovators, investors, and industry experts together to build relationships and make deals, which makes it a highly competitive event.
RESI Conference 2021
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors with strategic channel partners.
RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health.
RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.
APIE Therapeutics will participate in the Innovator’s Pitch Challenge Session. The IPC is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session.
Longevity Health & Innovation Conference
Longevity, Health & Innovation (LHI) is a new partnering conference focused on conditions related to aging, market challenges, and solutions via early-stage companies and their promising tech and products. LHI brings fundraising startups together with investors in longevity innovation to make deals in order that today’s seniors live longer, healthier lives.
APIE Therapeutics will participate in the Innovator’s Pitch Challenge Session. The IPC is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session.
Venture Connect 2021
Venture Connect Online is a digital experience that is designed to maximize the visibility of growing companies and help entrepreneurs build relationships with people (investors, peers, customers, and/or partners) who can help them scale.
Featured companies at Venture Connect will be showcased twice daily: 9:00am -10:30am & 2:00pm – 3:20pm
Attendees will have 24hr on-demand access to company’s personalized pitches via their private page on the Venture Connect interactive platform.
